NCT01610206 2021-02-25
A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer
University of Virginia
Phase 2 Completed
Clinical Trials
5 trialsNCT01713296 2015-10-08
Pazopanib in Relapsed and Refractory Small Cell Lung Cancer
Hellenic Oncology Research Group
Phase 2 Completed
NCT00430781 2015-05-08
Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
GlaxoSmithKline
Phase 2 Completed
NCT01165385 2014-11-17
PACIFIK
UNICANCER
Phase 1 Completed
NCT00350727 2013-04-19
VEG102857
GlaxoSmithKline
Phase 2 Completed